By the PharmaTradz BD Team. Updated October 2026.
Southeast Asia is not one market. Singapore's regulator offers short verification routes for products already approved by reference agencies, while Myanmar, Cambodia and Laos rely mostly on imports, with donor programmes playing a large part. Indonesia, Vietnam, Thailand and the Philippines sit in between, with sizeable local industries that still import much of their active ingredients.
What links them is ASEAN. Member states share a common dossier format, common technical guidelines and a joint assessment procedure, and several regulators now rely on assessments by reference agencies. Used well, these tools can cut months off a launch. Used badly, they create rework, because every country still issues its own licence and has its own labelling rules.
This guide covers where the region's medicines come from, how registration works, how to qualify a supplier, how tenders run, what to plan for in logistics, and where to find our country guides.
Where Southeast Asia's medicines come from
Local and regional manufacturers
Indonesia, Vietnam, Thailand, the Philippines and Malaysia all have domestic formulation plants making oral solids, liquids, topicals and, in some cases, injectables and infusions. Most of these plants buy their APIs and many excipients abroad. Intra-ASEAN trade matters too, and Singapore acts as a regional hub for distribution, warehousing and regional headquarters.
Asian generics and API producers
China and India are the main sources of APIs, intermediates and finished generics for the region. Buyers use them for high-volume chronic and acute therapies, anti-infectives and tender products. South Korea and Japan also supply finished products, APIs and some biosimilars.
Europe, the US and other regulated markets
Originator brands, vaccines, biologics, complex sterile products, oncology and many specialty medicines still come mainly from European, US and Japanese sites. For these products, the choice of source is usually driven by who holds a registrable dossier, not by price.
What buyers in the region typically source
- APIs and excipients for local formulation, often supported by a drug master file (see our API supplier service).
- Generics for diabetes, hypertension, lipids and other chronic conditions.
- Antibiotics, antimalarials, TB and HIV medicines for public programmes.
- Sterile injectables, infusions and lyophilised products for hospitals.
- Oncology medicines, biosimilars and vaccines.
- OTC products, nutraceuticals and herbal or traditional products, which are usually registered under separate categories.
- Contract manufacturing and private label, especially tablets, softgels and oral liquids.
Regulators and registration across ASEAN
ACTD and ACTR
The ASEAN Common Technical Dossier (ACTD) sets the format of a registration file in four parts: administrative data and product information, quality, nonclinical and clinical. The ASEAN Common Technical Requirements (ACTR) are the shared guidelines behind it, covering topics such as stability, process validation, analytical validation and bioavailability or bioequivalence. Both come from the ASEAN Pharmaceutical Product Working Group. Most regulators in the region accept ACTD, and some, including Singapore and Thailand, also accept ICH CTD. Part I is always country-specific, so expect local forms, labels and authorisation letters for each market.
ASEAN Joint Assessment
The ASEAN Joint Assessment procedure was set up in 2017 under the Joint Assessment Coordinating Group, with technical advice from WHO. It is voluntary. A company submits one application to at least three participating regulators at the same time, they assess it together and write a joint report, and each regulator then makes its own national decision. It suits priority products and companies planning a multi-country launch. A recent pilot extended the procedure to post-approval changes and line extensions.
National regulators and reliance routes
| Country | Regulator | Points to know |
|---|---|---|
| Indonesia | BPOM | The licence must be held by an Indonesian legal entity with an import licence. Labels and inserts must be in Bahasa Indonesia. A reference-country route exists for products approved by listed regulators. |
| Philippines | FDA Philippines (Center for Drug Regulation and Research) | Abridged review relies on one reference regulator and verification review on two. The importer or distributor needs a License to Operate. |
| Singapore | HSA | Full, abridged and verification routes. Verification relies on reference agencies: US FDA, EMA, Health Canada, MHRA, Swissmedic and TGA. |
| Thailand | Thai FDA | Abridged assessment using a reference regulator's unredacted report, a collaborative route for WHO-prequalified or reference-approved products, and ASEAN Joint Assessment. |
| Vietnam | Drug Administration of Vietnam (DAV), Ministry of Health | Circular 12/2025/TT-BYT governs registration from July 2025. Dossiers can rely on an EMA or stringent-regulator assessment if filed within five years of first approval. |
| Malaysia | NPRA | Facilitated Registration Pathway with abbreviated and verification reviews for new drugs and biologics, filed through the QUEST system. |
| Myanmar | Department of Food and Drug Administration (DFDA) | Registration under the Ministry of Health, with an electronic submission system. |
| Cambodia | Department of Drugs and Food, Ministry of Health | Imports need product registration and a licensed local importer. |
Reliance routes share the same conditions. The product must match the reference-approved version in formulation, sites and specifications, the filing must fall within a set window after the reference approval, and you will usually need the full, unredacted assessment report. If your supplier cannot get that report, plan for a standard review.
The ASEAN Sectoral Mutual Recognition Arrangement on GMP inspection, signed in 2009, lets member-state regulators accept each other's inspections of manufacturers located in ASEAN. It does not cover plants outside the region, so a foreign site may face a desk review or inspection by the importing regulator. Our dossier licensing and registration support can help you plan this.
How to qualify a supplier
- GMP certificate. Check it with the issuing authority, confirm the site address and dosage forms, and prefer inspections by PIC/S members or WHO prequalification. Our guide to checking a WHO-GMP certificate explains how.
- COPP. Ask for a WHO-format Certificate of Pharmaceutical Product from the exporting country's regulator. ASEAN regulators usually ask for one.
- CoA. Match each certificate of analysis to the registered specification and pharmacopoeia, and ask for three recent batches.
- Stability. The ASEAN stability guideline sets long-term testing at 30°C and 75% relative humidity (Zone IVb). For generics in conventional dosage forms, it typically means six months of data on two batches at submission; critical dosage forms and unstable APIs need twelve months on three batches. Zone II data alone will not do.
- Dossier. Confirm the file is in ACTD or ICH CTD format, the API part or DMF is available, and bioequivalence studies use a reference product the target regulator accepts.
- Labels and excipients. Plan local-language labels early, and check animal-derived excipients such as gelatin capsule shells for markets where halal status matters.
For a full checklist, see how to verify a pharmaceutical supplier.
Public procurement and tenders
Public buying differs by country. In Indonesia, public and private hospitals buy many products through the e-Katalog system, where LKPP negotiates prices with local licence holders, and products with certified local content can get priority. The Philippines runs government procurement through PhilGEPS. Vietnam and Thailand combine national or centralised bidding for selected molecules with tenders by individual hospitals.
In lower-income markets such as Myanmar, Cambodia and Laos, donor programmes matter. The Global Fund, UNICEF Supply Division and Gavi buy HIV, TB, malaria and vaccine products, usually requiring WHO prequalification or approval by a stringent regulator. In almost every case, the bidder or its local partner must hold a valid national registration before the tender closes.
See open opportunities on our pharma tenders page or read about government tender supply.
Logistics and cold chain into the region
The main sea gateways are Singapore, Port Klang, Laem Chabang, Tanjung Priok in Jakarta, Manila, Ho Chi Minh City, Hai Phong and Yangon. Changi, Bangkok Suvarnabhumi and Kuala Lumpur are the main air hubs, and Singapore is widely used for transhipment and regional warehousing.
- Air freight from Asia or Europe typically takes 2 to 5 days to arrival, plus customs clearance.
- Sea freight from East Asia typically takes 5 to 14 days, and from South Asia typically 7 to 20 days, depending on transhipment.
- Sea freight from Europe typically takes 3 to 5 weeks.
Island markets such as Indonesia and the Philippines add domestic transit after arrival. Heat and humidity are the main risks, so use temperature loggers, insulated packaging for ambient goods and validated 2–8°C lanes for biologics and vaccines. Our notes on good distribution practice and cold-chain pharma logistics cover what to check.
Common problems and practical fixes
| Problem | Practical fix |
|---|---|
| Stability data does not cover Zone IVb | Ask for 30°C/75% RH data before you sign. If none exists, budget the time for new studies. |
| Reliance route fails for lack of an assessment report | Confirm early that the supplier can obtain the unredacted report and that the product matches the reference version. |
| Labelling rejected | Draft local-language labels from the target regulator's format, not by translating another market's label. |
| Registration stalls with no local holder | Appoint a licensed local registrant or importer before filing, and agree who owns the licence. |
| MOQ too high for a small market | Combine orders across markets with shared packs where labels allow, or use small-batch manufacturing. |
| Temperature excursions in transit | Use GDP-qualified forwarders, data loggers and agreed excursion procedures. |
Southeast Asia country guide directory
- Indonesia sourcing guide and Indonesia country hub
- Philippines sourcing guide and Philippines country hub
- Singapore sourcing guide and Singapore country hub
- Thailand sourcing guide and Thailand country hub
- Myanmar sourcing guide and Myanmar country hub
- Malaysia country hub
- Cambodia country hub
How we can help
PharmaTradz works with GMP-certified manufacturers, CDMOs and API suppliers across Asia, Europe, the Americas and Africa. Tell us the product, target markets, dossier format and volumes, and we will shortlist suppliers with the documents you need. Start with a request for quotation.
Frequently Asked Questions(FAQs)
What dossier format do Southeast Asian regulators accept?
Most accept the ASEAN Common Technical Dossier (ACTD), which has four parts: administrative, quality, nonclinical and clinical. Some, including HSA in Singapore and the Thai FDA, also accept ICH CTD. Part I is always country-specific.
What stability data is needed for ASEAN registration?
Long-term data at 30°C and 75% relative humidity (Zone IVb) under the ASEAN stability guideline. For conventional generics, this is typically six months on two batches at submission; critical dosage forms and unstable APIs need twelve months on three batches.
Can a foreign manufacturer hold the marketing authorisation?
Usually not. Most ASEAN markets need a licensed local company as registrant or importer. In Indonesia, the BPOM licence must be held by an Indonesian legal entity with an import licence.
Does US FDA or EMA approval speed up registration?
Often, yes. HSA, NPRA, FDA Philippines, the Thai FDA, BPOM and DAV in Vietnam all have routes that rely on reference regulators. They usually need an unredacted assessment report, an identical product and filing within a set period after the reference approval.
What is the ASEAN Joint Assessment procedure?
A voluntary procedure started in 2017 with WHO technical advice. One application goes to at least three participating ASEAN regulators, who assess it together. Each regulator then issues its own national decision.
How long does shipping into Southeast Asia take?
Air freight typically takes 2 to 5 days plus clearance. Sea freight typically takes 5 to 14 days from East Asia, 7 to 20 days from South Asia and 3 to 5 weeks from Europe, depending on transhipment.
